Katherine Callaghan, MD

Specialty:

Obstetrics & Gynecology

Clinical Interests:

General obstetrics & gynecology, adolescent care, contraceptive management, PCOS, menopause, trauma-informed care, and harm-reduction approaches to gynecology.

Profile

A bohemian at heart, Dr. Callaghan has a wide range of interests and experiences both within the medicine field and in her personal life. Practicing both the Art and Science of medicine, she enjoys using Evidence-Based Medicine and active listening to tailor treatment plans to patient’s individual goals and needs.

Associate Professor in Obstetrics and Gynecology & Psychiatry, University of Massachusetts Medical School

Education

M.D., University of Massachusetts School of Medicine, Worcester MA

B.A., English and Creative Writing (Cum Laude), Middlebury College, Middlebury, VT

Awards & Honors

Alpha Omega Alpha – UmassChan Medical School, 2022

UMass Memorial Medical Group’s Hometown Hero, 2022

Excellence in Clinical Service – Women’s Faculty Committee Award (UMMS), 2021

Bahy Louca Award for Humanitarianism in Medicine (UMMS), 2014

The Golden Apple Award (UMMS), 2011, 2013, 2014, 2015, 2022

Presentations

National

MAT Waiver Eligibility Training – Virtual X Waiver Training ASAM / ACOG, 2020

“Opioid Use Disorder in Pregnancy and Postpartum” San Diego – Annual Meeting of the Academy of Consult-Liaison Psychiatry, 2019

Regional

“Supporting Patients at the Intersections of Vulnerability: how Exploitation and SUD Intersect” PNQIN Perinatal Opioid Project Summit – Harvard Medical School, 2021

“Caring for the Patient with Opioid Use Disorder in Pregnancy and Postpartum” MetroWest Medical Center, Framingham MA – Grand Rounds, 2021

“Substance Use Disorders in Pregnant & Postpartum Women” Yale – Addiction Medicine Grand Rounds, New Haven CT, 2021

“Treatment of Pregnant Women with Opioid Use Disorder” Stamford Hospital Grand Rounds, Stamford CT, 2020

“Pregnancy and Substance Use Disorder in the time of COVID19” The Perinatal-Neonatal QI Network of Massachusetts Virtual Town Hall, 2020

“Opioid Use Disorders in Pregnancy & Postpartum” New Haven – Yale’s Women’s Mental Health Conference, 2019

“Substance Use Disorder in Pregnancy and Postpartum” Cambridge Health Alliance – Grand Rounds, 2019

“Pregnant Women and New Moms with Opioid Use Disorder” Strategies for Hope: Berkshire Community College, 2019

“Screening Pregnant and Postpartum Women for Substance Use Disorder” Massachusetts Perinatal Quality Collaborative Fall Summit, 2018

“Pain Control Intrapartum and Postpartum for Women with Substance Use Disorders” Grand Rounds, Winchester Hospital, Department of Obstetrics and Gynecology, 2018

“Substance Use Disorders in Pregnancy & Postpartum” – Keynote Address, Addiction Division Training for the Committee for Public Counsel Services, Worc, MA, 2018

“Pregnant Women with Substance Use Disorders” – 2-hour workshop at the Massachusetts Early Intervention Consortium Conference – Framingham, MA, 2017

Publications

Peer-reviewed publications

Peeler M, Gupta M, Melvin P, Bryant AS, Diop H,Iverson R, Callaghan K, Wachman EM, Singh R, Houghton M, Greenfield SF, and Schiff DM “Racial and Ethnic Disparities in Maternal and Infant Outcomes Among Opioid-Exposed Mother–Infant Dyads in Massachusetts (2017–2019)” American Journal of Public Health 110, 1828-1836.

Ellsworth PI, Callaghan K, Gray E, Caldamone A. “Factors Involved in parental Decision-making for Surgical Correction of Vesicoureteral Reflux”. Jour of Urology 180(2):701-5 (Aug 2008).

Books & Chapters

Callaghan K “Treatment of Substance Use Disorder in Pregnancy” In: periFACTS, OB/GYN Academy, University of Rochester 2019

Callaghan K, Tasillo D. “Galactorrhea” In: The Five-Minute Clinical Consult Vols 19, 20, 21, 22. Lippincott & Williams, New York, NY, 2011, 2012, 2013.

Callaghan K, Tasillo D. “Fibrocystic Changes of the Breast” In: The Five-Minute Clinical Consult Vols: 19, 20, 21, 22. Lippincott & Williams, New York, NY, 2011, 2012, 2013.

Callaghan K, Tasillo D. “Vulvovaginitis, Prepubescent” In: The Five-Minute Clinical Consult Vols: 19, 20, 21, 22. Lippincott & Williams, New York, NY, 2012, 2013.

Callaghan K, Tasillo D. “Body Dysmorphic Disorder” In: The Five-Minute Clinical Consult Vols: 20, 21, 22. Lippincott & Williams, New York, NY, 2012, 2013, 2014.

Non-peer-reviewed publications

Harrington A, Babu K, Ledwith J, Ponce Martinez C, Callaghan K, Mullin D. Opinion: Remove the waiver requirement for buprenorphine prescribing. Boston Globe (February 22, 2021)